EUVIMEDEUVIMED entdecken
Crossref

Genetic risk assessment in carrier testing for spinal muscular atrophy

Shuji Ogino, Debra G B Leonard, Hanna Rennert, Warren J Ewens, Robert B Wilson

American Journal of Medical Genetics · 15.07.2002 · 110 (4) · 301-307

DOI: 10.1002/ajmg.10425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics, online erschienen am 21.06.2002. Verfasst von Shuji Ogino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pathology Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvani…. Die Arbeit wurde bisher 166-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As evidenced by the complete absence of a functionally critical sequence in exon 7, approximately 94% of individuals with clinically typical spinal muscular atrophy (SMA) lack both copies of the SMN1 gene at 5q13. Hence most carriers have only one copy of SMN1 . Combining linkage and dosage analyses for SMN1 , we observed unaffected individuals who have two copies of SMN1 on one chromosome 5 and zero copies of SMN1 on the other chromosome 5. By dosage analysis alone, such individuals, as well as carriers of non‐deletion disease alleles, are indistinguishable from non‐carrier individuals. We report that approximately 7% of unaffected individuals without a family history of SMA have three or four copies of SMN1 , implying a higher frequency of chromosomes with two copies of SMN1 than previously reported. We present updated calculations for disease and non‐disease allele frequencies and we describe how these frequencies can be used for genetic risk assessment in carrier testing for SMA. © 2002 Wiley‐Liss, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AllelesCyclic AMP Response Element-Binding ProteinDNAGene DosageGene FrequencyGenetic Carrier ScreeningGenetic TestingGenotypeHumansMuscular Atrophy, SpinalMutationNerve Tissue ProteinsRNA-Binding ProteinsRisk AssessmentSMN Complex ProteinsSurvival of Motor Neuron 1 Protein

Substanzen

Cyclic AMP Response Element-Binding ProteinNerve Tissue ProteinsRNA-Binding ProteinsSMN Complex ProteinsSMN1 protein, humanSurvival of Motor Neuron 1 ProteinDNA

Autor:innen und Institutionen

  • Molecular Pathology Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA.

Zitieren

APA

Ogino, S., Leonard, D. G., Rennert, H., Ewens, W. J., & Wilson, R. B. (2002). Genetic risk assessment in carrier testing for spinal muscular atrophy. American Journal of Medical Genetics, 110(4), 301-307. https://doi.org/10.1002/ajmg.10425

Vancouver

Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB. Genetic risk assessment in carrier testing for spinal muscular atrophy. American Journal of Medical Genetics. 2002;110(4):301-307. doi:10.1002/ajmg.10425

BibTeX
@article{Ogino2002,
  author = {Ogino, Shuji and Leonard, Debra G B and Rennert, Hanna and Ewens, Warren J and Wilson, Robert B},
  title = {Genetic risk assessment in carrier testing for spinal muscular atrophy},
  journal = {American Journal of Medical Genetics},
  year = {2002},
  volume = {110},
  number = {4},
  pages = {301--307},
  doi = {10.1002/ajmg.10425}
}
Kostenlos starten →